IPIC2025 CME Accreditation

The IPIC 2025 International Primary Immunodeficiencies Congress, PRAGUE, Czech Republic, 05/11/2025 – 07/11/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 13.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Official Italian Agency for AIFA Procedure

Any Italian pharmaceutical company supporting or participating in a congress abroad is subject to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).

The request for authorisation must be submitted within 60 days before the starting date of the event. The appointed agency collector for AIFA authorisation is:

AIM Group International – AIM Education S.r.l.

Cristina Ghidoli

Viale Enrico Forlanini, 23
20134 Milan, Italy

Tel. +39 02 56601.1

e-mail: aifa@aimgroup.eu c.ghidoli@aimgroup.eu

How How to Claim your CME Credits:

After the congress, scan your badge and stop by the registration desk to complete the CME claim form.